Article
MAO-A Inhibition by Metaxalone Reverts IL-1β-Induced Inflammatory Phenotype in Microglial Cells.
International journal of molecular sciences - 5 Aug 2021
Pallio Giovanni, D'Ascola Angela, Cardia Luigi, Mannino Federica, Bitto Alessandra, Minutoli Letteria, Picciolo Giacomo, Squadrito Violetta, Irrera Natasha, Squadrito Francesco, Altavilla Domenica
Abstract excerpt
Experimental and clinical studies have suggested that several neurological disorders are associated with the occurrence of central nervous system neuroinflammation. Metaxalone is an FDA-approved muscle relaxant that has been reported to inhibit monoamine oxidase A (MAO-A). The aim of this study was to investigate whether metaxalone might exert antioxidant and anti-inflammatory effects in HMC3 microglial cells. An...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
